18.11.2014 Views

09/2009 - Državni zavod za intelektualno vlasništvo

09/2009 - Državni zavod za intelektualno vlasništvo

09/2009 - Državni zavod za intelektualno vlasništvo

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 16, 20<strong>09</strong>, 9, 3373 – 3601 3551<br />

Podnositelj europske MKP Broj objave europske Naziv izuma<br />

prijave patenta<br />

prijave patenta<br />

(71) (51) (97) (54)<br />

Imperial Innovations Limited, GB A61K 38/26 (2006.01) EP 1985304 Novel compounds and their effects on feeding behaviour<br />

C07K 14/435 (2006.01)<br />

InBev S.A., BE A23L 1/30 (2006.01)<br />

EP 2<strong>09</strong>9317 * SPENT HOP PRODUCTS, THEIR CONTENT IN<br />

A23L 2/52 (2006.01)<br />

STILBENES AND THEIR USE AS ANTIOXIDANT FOR<br />

A23L 2/56 (2006.01)<br />

COMESTIBLE PRODUCTION<br />

C12C 3/08 (2006.01)<br />

C12C 11/11 (2006.01)<br />

InBev S.A., BE B01D 37/02 (2006.01)<br />

EP 2<strong>09</strong>9545 * USE OF A PRIMARY LIQUID<br />

FILTRATION/STABILIZATION INSTALLATION FOR<br />

Incyte Corporation, US A61K 31/198 (2006.01)<br />

A61K 31/519 (2006.01)<br />

C07D 487/04 (2006.01)<br />

Infinity Discovery, Inc., US C07D 261/02 (2006.01)<br />

C07D 413/12 (2006.01)<br />

A61K 31/4155 (2006.01)<br />

A61P 35/00 (2006.01)<br />

Infinity Discovery, Inc., US A01N 43/42 (2006.01)<br />

A61K 31/44 (2006.01)<br />

"Infoglass Group International Limited", G<strong>09</strong>F 13/00 (2006.01)<br />

CN<br />

Ingeteam, S.A., ES H02P 9/00 (2006.01)<br />

INSTITUT NATIONAL DE LA SANTE<br />

ET DE LA RECHERCHE MEDICALE<br />

(INSERM), FR<br />

Institute of the Human Brain, Russian<br />

Academy of Science (IHB RAS), RU<br />

C07K 16/28 (2006.01)<br />

A61K 39/00 (2006.01)<br />

C07C 229/24 (2006.01)<br />

C07B 59/00 (2006.01)<br />

C07C 251/24 (2006.01)<br />

C07C 3<strong>09</strong>/73 (2006.01)<br />

C07C 271/22 (2006.01)<br />

C07D 207/16 (2006.01)<br />

A61K 51/04 (2006.01)<br />

A61K 31/195 (2006.01)<br />

Intercell AG, AT A61K 39/<strong>09</strong> (2006.01)<br />

C07K 14/315 (2006.01)<br />

G01N 33/569 (2006.01)<br />

International Institute of Cancer<br />

Immunology, Inc., JP<br />

C12N 15/12 (2006.01)<br />

A61K 31/7088 (2006.01)<br />

A61K 38/00 (2006.01)<br />

A61K 48/00 (2006.01)<br />

A61P 35/00 (2006.01)<br />

A61P 35/02 (2006.01)<br />

C07K 14/82 (2006.01)<br />

C12N 5/06 (2006.01)<br />

C12Q 1/02 (2006.01)<br />

G01N 33/574 (2006.01)<br />

Intervet International BV, NL A61K 9/00 (2006.01)<br />

IRM LLC, BM C07K 16/28 (2006.01)<br />

A61K 39/395 (2006.01)<br />

A61P 3/10 (2006.01)<br />

IRM LLC, BM C07D 213/74 (2006.01)<br />

C07D 239/48 (2006.01)<br />

C07D 239/95 (2006.01)<br />

C07D 401/12 (2006.01)<br />

ISAGRO S.p.A., IT A01P 13/02 (2006.01)<br />

A01N 47/36 (2006.01)<br />

A01N 37/22 (2006.01)<br />

A01N 37/26 (2006.01)<br />

A01N 43/12 (2006.01)<br />

A01N 41/10 (2006.01)<br />

A01N 37/18 (2006.01)<br />

A01N 43/653 (2006.01)<br />

A01N 43/80 (2006.01)<br />

A01N 39/04 (2006.01)<br />

A01N 43/40 (2006.01)<br />

A01N 47/38 (2006.01)<br />

A01N 43/82 (2006.01)<br />

A01N 43/50 (2006.01)<br />

A01N 47/30 (2006.01)<br />

EP 2<strong>09</strong>9447 *<br />

EP 2<strong>09</strong>4673 *<br />

EP 2<strong>09</strong>6917 *<br />

EP 2<strong>09</strong>9011 *<br />

EP 2<strong>09</strong>5497 *<br />

EP 2089432 *<br />

EP 2086924 *<br />

EP 2<strong>09</strong>7100 *<br />

EP 2<strong>09</strong>8595 *<br />

EP 2<strong>09</strong>7063 *<br />

EP 2087007 *<br />

EP 2<strong>09</strong>1918 *<br />

EP 2<strong>09</strong>4<strong>09</strong>3 *<br />

TRIPLE PURPOSE.<br />

IMIDAZOTRIAZINES AND IMIDAZOPYRIMIDINES AS<br />

KINASE INHIBITORS<br />

COMPOUNDS AND METHODS FOR INHIBITING THE<br />

INTERACTION OF BCL PROTEINS WITH BINDING<br />

PARTNERS<br />

CYCLOPAMINE ANALOGS<br />

LIGHT INFORMATION MODULE<br />

A LOW VOLTAGE RIDE THROUGH SYSTEM FOR A<br />

VARIABLE SPEED WIND TURBINE HAVING AN<br />

EXCITER MACHINE AND A POWER CONVERTER<br />

NOT CONNECTED TO THE GRID<br />

ANTI-GLYCOPROTEIN VI SCFV FRAGMENT FOR<br />

TREATMENT OF THROMBOSIS<br />

[F-18]-LABELED L-GLUTAMIC ACID, [F-18]-LABELED<br />

L-GLUTAMINE, DERIVATIVES THEREOF AND USE<br />

THEREOF AND PROCESSES FOR THEIR<br />

PREPARATION<br />

PEPTIDES PROTECTIVE AGAINST S. PNEUMONIAE<br />

AND COMPOSITIONS, METHODS AND USES<br />

RELATING THERETO<br />

HLA-A*1101-RESTRICTED WT1 PEPTIDE AND<br />

PHARMACEUTICAL COMPOSITION COMPRISING<br />

THE SAME<br />

HELICALLY-SHAPED DRUG DELIVERY SYSTEM<br />

AGONIST TRKB ANTIBODIES AND USES THEREOF<br />

COMPOUNDS AND COMPOSITIONS AS PROTEIN<br />

KINASE INHIBITORS<br />

HERBICIDAL COMPOSITIONS<br />

ISSN 1331-2030

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!